Company to Submit Product Development Plan to Treat External Squamous Cell Carcinoma (SCC) in Horses
Toronto, Ontario and Philadelphia, Pennsylvania -
Newsfile Corp. - December 12, 2024 - Medicus Pharma Ltd. (NASDAQ: MDCX) (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce that its Investigational New Animal Drug (INAD File...
Read more: Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing...